Literature DB >> 8764114

Complex cadherin expression in renal cell carcinoma.

T Shimazui1, L A Giroldi, P P Bringuier, E Oosterwijk, J A Schalken.   

Abstract

E-cadherin is an intercellular adhesion protein expressed by most epithelia. Decreased expression of E-cadherin correlates with tumor aggressiveness in most carcinomas. In renal cell carcinoma (RCC), however, this correlation is not well established and the prevalence of negative tumors is higher than in other carcinomas. Our immunofluorescence study of alpha-catenin expression in 20 RCC cell lines revealed a typical honeycomb staining pattern in all of the lines, whereas only six expressed E-cadherin. This suggested that other cadherins are expressed in RCC lines. Indeed, immunoprecipitation with an anti-alpha-catenin antibody resulted in coprecipitation of proteins of Mr 125,000-135,000. Using Western blot, these proteins react with a pan-cadherin antibody. To identify these cadherin related proteins, RT-PCR using degenerated primers and sequence comparisons was carried out. We then assessed the expression of the identified cadherins. N-cadherin mRNA was present in all cell lines; and cadherin 6 mRNA was seen in 16 lines. Cadherin 11 (mRNA) and E-cadherin (protein) were expressed in five and six lines, respectively. A cadherin 4 transcript was observed in only one line, whereas no P-cadherin protein could be detected. Expression of the four main cadherins was also found in normal kidney (two samples tested) and RCC specimens (four samples). Thus, RCC and normal kidney express a complex set of cadherins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8764114

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

Review 1.  Alpha-catenin: at the junction of intercellular adhesion and actin dynamics.

Authors:  Agnieszka Kobielak; Elaine Fuchs
Journal:  Nat Rev Mol Cell Biol       Date:  2004-08       Impact factor: 94.444

2.  Cadherin-11, a marker of the mesenchymal phenotype, regulates glioblastoma cell migration and survival in vivo.

Authors:  Harpreet Kaur; Polly J Phillips-Mason; Susan M Burden-Gulley; Amber E Kerstetter-Fogle; James P Basilion; Andrew E Sloan; Susann M Brady-Kalnay
Journal:  Mol Cancer Res       Date:  2012-01-20       Impact factor: 5.852

3.  VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail.

Authors:  Andrew J Evans; Ryan C Russell; Olga Roche; T Nadine Burry; Jason E Fish; Vinca W K Chow; William Y Kim; Arthy Saravanan; Mindy A Maynard; Michelle L Gervais; Roxana I Sufan; Andrew M Roberts; Leigh A Wilson; Mark Betten; Cindy Vandewalle; Geert Berx; Philip A Marsden; Meredith S Irwin; Bin T Teh; Michael A S Jewett; Michael Ohh
Journal:  Mol Cell Biol       Date:  2006-10-23       Impact factor: 4.272

Review 4.  Cadherins function during the collective cell migration of Xenopus Cranial Neural Crest cells: revisiting the role of E-cadherin.

Authors:  Hélène Cousin
Journal:  Mech Dev       Date:  2017-04-30       Impact factor: 1.882

5.  Combined blood/tissue analysis for cancer biomarker discovery: application to renal cell carcinoma.

Authors:  Donald J Johann; Bih-Rong Wei; DaRue A Prieto; King C Chan; Xiaying Ye; Vladimir A Valera; R Mark Simpson; Paul A Rudnick; Zhen Xiao; Haleem J Issaq; W Marston Linehan; Stephen E Stein; Timothy D Veenstra; Josip Blonder
Journal:  Anal Chem       Date:  2010-03-01       Impact factor: 6.986

6.  N- and E-cadherins in Xenopus are specifically required in the neural and non-neural ectoderm, respectively, for F-actin assembly and morphogenetic movements.

Authors:  Sumeda Nandadasa; Qinghua Tao; Nikhil R Menon; Janet Heasman; Christopher Wylie
Journal:  Development       Date:  2009-03-11       Impact factor: 6.868

7.  Expression of Ksp-cadherin during kidney development and in renal cell carcinoma.

Authors:  C Thedieck; M Kuczyk; K Klingel; I Steiert; C A Müller; G Klein
Journal:  Br J Cancer       Date:  2005-06-06       Impact factor: 7.640

Review 8.  Combination of mTOR and MAPK Inhibitors-A Potential Way to Treat Renal Cell Carcinoma.

Authors:  Ashutosh Chauhan; Deepak Kumar Semwal; Satyendra Prasad Mishra; Sandeep Goyal; Rajendra Marathe; Ruchi Badoni Semwal
Journal:  Med Sci (Basel)       Date:  2016-10-17

9.  Interleukin enhancer-binding factor 3 and HOXC8 co-activate cadherin 11 transcription to promote breast cancer cells proliferation and migration.

Authors:  Yang Zhang; Chenchen Yang; Mingsheng Zhang; Houli Liu; Chen Gong; Jie Zhang; Shanshan Xu; Jin Zou; Yuanzhong Kai; Yong Li
Journal:  Oncotarget       Date:  2017-11-18

10.  Hippo signaling mediates proliferation, invasiveness, and metastatic potential of clear cell renal cell carcinoma.

Authors:  Ute Schütte; Savita Bisht; Lukas C Heukamp; Moritz Kebschull; Alexandra Florin; Jens Haarmann; Per Hoffmann; Gerd Bendas; Reinhard Buettner; Peter Brossart; Georg Feldmann
Journal:  Transl Oncol       Date:  2014-03-04       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.